Suppr超能文献

[双膦酸盐相关颌骨坏死。最新进展]

[Bisphosphonate-related osteonecrosis of the jaws. An update].

作者信息

Cardona F, Bagán J V, Sáinz E, Figuerido J, Giner F, Vidán F J

机构信息

Sección de Salud Bucodental, Centro Conde Oliveto, Pamplona, Spain.

出版信息

An Sist Sanit Navar. 2009 Sep-Dec;32(3):413-21. doi: 10.23938/ASSN.0138.

Abstract

Bisphosphonates are widely used drugs, primarily for osteoporosis and also in oncology. A drug-induced side effect or complication, which only recently came to light in 2003, is osteonecrosis of the jaw. This study reviews the chemical characteristics of the various bisphosphonates, their possible mechanism of action, relative potency, the commercial products available on the spanish pharmaceutical market and the indications for bisphosphonate treatment. The study also considers osteonecrosis of the jaw with regard to its onset, concept, clinical stages, why this pathology affects the jaws, its risk factors, incidence, the attitude to be adopted by dentists with patients taking bisphosphonates, a quick review of the treatment and the possible prediction of osteonecrosis.

摘要

双膦酸盐是广泛使用的药物,主要用于治疗骨质疏松症,也用于肿瘤学领域。药物性副作用或并发症——颌骨坏死,直到2003年才被发现。本研究回顾了各种双膦酸盐的化学特性、可能的作用机制、相对效力、西班牙药品市场上的商业产品以及双膦酸盐治疗的适应症。该研究还探讨了颌骨坏死的发病情况、概念、临床分期、这种病理为何影响颌骨、其危险因素、发病率、牙医对服用双膦酸盐患者的态度、治疗的简要回顾以及颌骨坏死的可能预测。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验